Market Opportunity
AI-assisted clinical scribing to cut physician review time targets a $4.2B = 210,000 hospitals and outpatient clinics globally x $20,000 ACV (enterprise hospital pricing and deployment, includes integration and compliance features) total addressable market with medium saturation and a year-over-year growth rate of 25% estimated adoption growth for AI scribing in hospitals over next 5 years.
Key trends driving demand: AI transcription accuracy improvements -- lower error rates make draft notes more usable and reduce review time.; EHR interoperability via FHIR APIs -- easier insertion of draft notes and audit trails into clinical workflows.; Institutional pilots and procurement cycles -- hospitals prefer staged trials, creating predictable pilot-to-deployment funnels..
Key competitors include Nuance Dragon Medical One (Microsoft), Suki AI, Augmedix, Google Cloud Healthcare / Medical Speech-to-Text, Human scribe services and internal EHR templates (workarounds).